DIAGNOS Announces an Additional Expansion of Successful Program in the UAE
11 Mars 2014 - 5:09PM
Marketwired
DIAGNOS Announces an Additional Expansion of Successful Program in
the UAE
BROSSARD, QUEBEC--(Marketwired - Mar 11, 2014) - Diagnos Inc.
("DIAGNOS" or "the Corporation") (TSX-VENTURE:ADK), a leader in
healthcare technical services including, screening, software and
algorithm development, data analysis, and image processing,
announced today a further expansion of the agreement announced on
November 26th 2013 to further increase screening capacity in the
country.
"Having announced a
100% expansion of our screening program in the UAE in November
2013, we are very pleased to have this further 50% expansion only 4
months later. Our client has seen a material impact on their
business in the UAE and asked us for this increase to capture
emerging market demand for their products and consequently for our
services which are helping drive that demand. As a result of this
expansion the client will now have a total of 12 screening units
operating across the UAE and will be able to pursue further
opportunities with key health care providers in the country. We are
very happy that our service is appreciated by the client and it is
demonstrating a very positive impact on their bottom line, as
evidenced by subsequent expansions of the program. Due to our
favourable program performance and strong client relationship, we
are now pursuing materially important leads generated by our
client's complimentary referrals to key country-level
decision-makers worldwide within the organization." said Peter
Nowacki, Diagnos' Vice-President.
About DIAGNOS
Founded in 1998,
DIAGNOS is a publicly traded Canadian corporation, with a mission
to commercialize technologies to improving decision making
processes in different sectors. DIAGNOS offers products, services,
and solutions to clients in a variety of fields including
healthcare and natural resources.
About DIAGNOS Healthcare
DIAGNOS Healthcare
is a business division with DIAGNOS Inc., achieving international
recognition as leader in healthcare technical services including,
screening, software and algorithm development, data analysis, and
image processing. Through its Healthcare division, DIAGNOS offers
turn-key diabetic retinopathy screening services to patients in
various locations around the world.
Neither the TSX
Venture Exchange nor its Regulation Service Provider (as that term
is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
For further
information on DIAGNOS, please visit our website at www.diagnos.com
or the SEDAR website at www.sedar.com.
Andre LarentePresidentDIAGNOS Inc.(450) 678-8882 ext 224
Diagnos (TSXV:ADK)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Diagnos (TSXV:ADK)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024